06.03.2013 Views

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

IMS Company Profiles - Report Buyer

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />

Prin ci pal Prod ucts:<br />

LINEX (antidiarrheal mi cro-or gan ism)<br />

AMOKSIKLAV (pen i cil lin broad spec trum)<br />

KETONAL (antirheumatic non-steroidal;<br />

antirheumatic top i cal)<br />

PERSEN (hyp notic/sed a tive)<br />

IMMUNAL (ther a peu tic prod uct other)<br />

Ther a peu tic Range:<br />

antidiarrheals, elec tro lyte re plac ers, in tes ti nal<br />

anti-inflammatorie s 29%<br />

antibacterials sys temic 18%<br />

anti rheu ma tics sys temic 9%<br />

psycholeptics 8%<br />

ther a peu tic prod ucts other 7%<br />

Lead ing Dose Forms:<br />

cap sules 42%<br />

tab lets 22%<br />

coated tab lets 13%<br />

liq uids 10%<br />

am poules 6%<br />

NOVARTIS<br />

Full Name: ZAO Novartis En ter prise AG<br />

Street Ad dress: 123104 Mos cow, B.<br />

Palaschweskij Pereulok 15/A<br />

Tel: +7 95 967 1270<br />

Fax: +7 95 973 1268<br />

Email: pharma@novartis.ru<br />

Home Page: www.novartis.ru<br />

De scrip tion: Rep re sen ta tive of fice. Re searcher,<br />

pro moter, sales/detailer. Prod uct ranges in clude:<br />

phar ma ceu ti cal prod ucts (branded, pre scrip tion),<br />

hos pi tal pharmaceuticals. Established 1997.<br />

Con tacts (Pharm): Chair man: Ger ald Schuh;<br />

Com mer cial Op er a tions: Anton Pronin, Natalia<br />

Lobodenko; Gen eral Con tact: Ger ald Schuh<br />

Sub sid iary of: Novartis, Swit zer land (100%)<br />

Phar ma ceu ti cal Sales: US$ 55-60 mil lion<br />

Prod ucts (% of Sales by Lead ing 5): 50-55%<br />

Ther a peu tic Classes (% of Sales by Lead ing<br />

5): 50-55%<br />

Dose Forms (% of Sales by Lead ing 5):<br />

85-90%<br />

Prin ci pal Prod ucts:<br />

VOLTAREN (antirheumatic non-steroidal)<br />

ADELPHAN ESIDREX (antihypertensive<br />

non-herbal with di uretic)<br />

MIACALCIC (calcitonin)<br />

GLIVEC (antineoplastic other)<br />

LAMISIL (antifungal sys temic)<br />

Ther a peu tic Range:<br />

anti rheu ma tics sys temic 14%<br />

antihypertensives 13%<br />

hor mones other 9%<br />

antineoplastics 8%<br />

antifungals sys temic 7%<br />

Lead ing Dose Forms:<br />

tab lets 31%<br />

cap sules 18%<br />

am poules 16%<br />

coated tab lets 14%<br />

liq uids 11%<br />

NOVARTIS CON SUMER HEALTH<br />

Street Ad dress: 123317 Mos cow,<br />

Naberezhnaya Tower Busi ness Cen ter, 14th Floor,<br />

Krasnopresnenskaya nab., 18<br />

Tel: +7 95 969 2165<br />

Fax: +7 95 969 2166<br />

Home Page: www.novartis.ru<br />

Sub sid iary of: Novartis, Swit zer land (100%)<br />

Phar ma ceu ti cal Sales: US$ 95-100 mil lion<br />

Prod ucts (% of Sales by Lead ing 5): 60-65%<br />

Ther a peu tic Classes (% of Sales by Lead ing<br />

5): 85-90%<br />

Dose Forms (% of Sales by Lead ing 5):<br />

95-100%<br />

Prin ci pal Prod ucts:<br />

TERAFLU (cold prep a ra tion with out anti-in fec tive)<br />

OTRIVIN (na sal prep a ra tion top i cal)<br />

LAMISIL (dermatological antifungal)<br />

DLIANOS (na sal prep a ra tion top i cal)<br />

VOLTAREN (antirheumatic top i cal)<br />

Ther a peu tic Range:<br />

cough and cold prep a ra tions 36%<br />

na sal prep a ra tions 28%<br />

dermatological antifungals 11%<br />

an ti his ta mines sys temic 8%<br />

anti rheu ma tics top i cal 7%<br />

Lead ing Dose Forms:<br />

liq uids 37%<br />

pow ders/gran ules 31%<br />

gels/sols 14%<br />

creams 9%<br />

tab lets 6%<br />

SAUDI ARABIA<br />

NOVARTIS<br />

Full Name: Novartis Pharma Ser vices AG<br />

Postal Ad dress: PO Box 16032, Ri yadh 11464<br />

Street Ad dress: Prince Mo ham med Bin<br />

Abdulaziz Street, Tahlia St, Suleymania, Ri yadh<br />

11464<br />

© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 202

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!